[Biology of haemostasis abnormalities – summary]

Haute Autorité de Santé
Record ID 32016000273
French
Authors' objectives: Haemostasis comprises all the mechanisms which prevent spontaneous bleeding and stop haemorrhages by repairing the breach in the vascular system. The National Salaried Workers' Health Insurance Fund (CNAMTS) asked HAS to assess the value of the different laboratory tests for haemostasis abnormalities with a view to updating the section in the Nomenclature of Procedures in Laboratory Medicine (NABM) containing the procedures in laboratory medicine for measuring abnormalities of haemostasis (subsection 5-02). Those tests are: the bleeding time test (Duke's test, Ivy's incision test or Ivy's 3-point test), the thrombin time and correction of the thrombin time, the photometric platelet aggregation test, the test for antibodies to platelet factor 4 where heparin-induced thrombocytopenia type II is suspected, a test for and titration of antihaemophilic factor inhibitors, a test for and identification of the lupus anticoagulant, a test for the G1691A mutation in the factor V (Leiden factor) gene and the G20210A mutation in the factor II gene when testing for risk factors for venous thromboembolism. This assessment is based on a critical analysis of the literature made by the Haute Autorité de Santé, and reviewed by experts in haemostasis. It takes into account the arguments of a group of experts assembled by CNAMTS on which CNAMTS based its request.
Details
Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: France
MeSH Terms
  • Humans
  • Hemostasis
  • Blood Coagulation Tests
  • Insurance, Health
  • Risk Factors
Contact
Organisation Name: Haute Autorité de Santé
Contact Address: 2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name: has.seap.secretariat@has-sante.fr
Contact Email: has.seap.secretariat@has-sante.fr
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.